ACCURYN MEDICAL Trademark
Trademark Overview
On Wednesday, February 14, 2024, a trademark application was filed for ACCURYN MEDICAL with the United States Patent and Trademark Office. The USPTO has given the ACCURYN MEDICAL trademark a serial number of 98405493. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, September 6, 2024. This trademark is owned by Potrero Medical, Inc.. The ACCURYN MEDICAL trademark is filed in the Medical Instrument Products and Computer & Software Services & Scientific Services categories with the following description:
Catheters for use in medical devices; All of the foregoing excluding medical devices used for blood glucose monitoring and medical devices used for peripherally inserted central catheters; Medical apparatus and instruments for monitoring and analyzing body fluids in the bladder, body fluid output rates, intra-abdominal pressure, CAUTI risk, acute kidney injury, and vital signs; Medical diagnostic apparatus for testing and measurement of physiological parameters in the bladder for intensive patient care incorporating recorded software for data transmission to electronic medical record management systems
Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for medical device predictive health platforms to predict patient adverse outcomes
General Information
Serial Number | 98405493 |
Word Mark | ACCURYN MEDICAL |
Filing Date | Wednesday, February 14, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Friday, September 6, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
NOT AVAILABLE | "Medical" |
Goods and Services | Catheters for use in medical devices; All of the foregoing excluding medical devices used for blood glucose monitoring and medical devices used for peripherally inserted central catheters; Medical apparatus and instruments for monitoring and analyzing body fluids in the bladder, body fluid output rates, intra-abdominal pressure, CAUTI risk, acute kidney injury, and vital signs; Medical diagnostic apparatus for testing and measurement of physiological parameters in the bladder for intensive patient care incorporating recorded software for data transmission to electronic medical record management systems |
Goods and Services | Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for medical device predictive health platforms to predict patient adverse outcomes |
Classification Information
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, February 14, 2024 |
Primary Code | 010 |
First Use Anywhere Date | Thursday, February 8, 2024 |
First Use In Commerce Date | Thursday, February 8, 2024 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, February 14, 2024 |
Primary Code | 042 |
First Use Anywhere Date | Thursday, February 8, 2024 |
First Use In Commerce Date | Thursday, February 8, 2024 |
Trademark Owner History
Party Name | Potrero Medical, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Hayward, CA 94545 |
Trademark Events
Event Date | Event Description |
Wednesday, February 14, 2024 | NEW APPLICATION ENTERED |
Monday, June 17, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, September 6, 2024 | NON-FINAL ACTION WRITTEN |
Friday, September 6, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, September 6, 2024 | NON-FINAL ACTION E-MAILED |
Friday, September 6, 2024 | ASSIGNED TO EXAMINER |